Multiple pro-inflammatory signaling pathways

"Multiple pro-inflammatory signaling pathways" refers to several parallel and interacting signaling cascades that coordinate cellular and molecular responses to infection, injury, or immune challenge. The main pathways typically cited include the **nuclear factor kappa-B (NF-κB) pathway**, the **mitogen-activated protein kinase (MAPK) pathway**, the **Janus kinase/signal transducer and activator of transcription (JAK-STAT) pathway**, and pathways initiated by pattern-recognition receptors such as **Toll-like receptors (TLRs)**, **NOD-like receptors (NLRs)**, and the **inflammasome complex**[3][4][6][7][9]. These pathways trigger the production of pro-inflammatory cytokines (e.g., IL-1β, IL-6, TNF-α), chemokines, and other mediators critical for immune defense, but their chronic or excessive activation underlies the pathogenesis of numerous inflammatory and autoimmune diseases as well as cancer progression[1][2][3][4][6][9]. Because each pathway encompasses many proteins and molecular targets, "multiple pro-inflammatory signaling pathways" does not specify a single targetable molecule and should instead be mapped to its individual components, which may be therapeutically targeted. **Note:** This entry does not correspond to an individual molecule, receptor, or drug target, but rather describes an umbrella category encompassing many possible therapeutic targets and physiological pathways. The phrase is too generic for structured target annotation per the conventions specified above.

Inhibition of pro-inflammatory cytokine production; Inhibition of key transcription factors (e.g., NF-κB, STAT3); Blockade of upstream receptor signaling (e.g., TLR antagonists); Disruption of kinase signaling (e.g., JAK inhibitors); Inhibition of inflammasome activation